CELOX Medical

CELOX Medical is a UK-based global med-tech company with over 25 years of experience in developing lifesaving medical technologies. The company specializes in bleeding control, women’s health, advanced wound care, and infection prevention. CELOX Medical manages the entire product lifecycle, from research and development to manufacturing, regulatory approval, clinical evaluation, and marketing, ensuring comprehensive support for distribution partners worldwide. The core innovation of CELOX Medical is the CELOX™ technology, a patented chitosan-based hemostatic agent that effectively stops bleeding in traumatic and surgical wounds. This technology has been FDA-approved since 2006 and is widely used in trauma management, hospital patient care, and maternal health, particularly for addressing postpartum hemorrhage. CELOX Medical offers a range of products, including hemostatic agents like OMNI-STAT® and advanced wound care dressings under the AVARUS™ brand, designed for managing various types of wounds. The company aims to save and improve lives through evidence-based innovations and strives to lead the medical device industry with accessible and sustainable healthcare solutions.

• Employees 95
• Founded 1999
• Annual Revenue $8000000